What is Cytek Biosciences, Inc.'s long-lived assets?

Cytek Biosciences, Inc. (CTKB) reported long-lived assets of $20.47M in Q1 2026.

Cytek Biosciences, Inc. CTKB Long-Lived Assets

Long-Lived Assets at other companies

eBayEBAY

$1.77B+4.5%

Keysight TechnologiesKEYS

$1.66B+14.3%

Phillips 66PSX

$51B+2.7%

AzentaAZTA

$54K—

OFL

Omega FlexOFLX

$186K+72.2%

Foster (Lb) Co.FSTR

$551K-1.4%

Segments

By geography

See full

APAC$9.52M+2.5%

EMEA$436K+3.3%

Other financials

Income statement

See full

Revenue$44.1M+6.5%

Gross profit$21.3M+5.4%

Operating income-$18.5M-23.3%

Net income-$18.9M-65.5%

EPS (diluted)-$0.15-66.7%

Balance sheet

See full

Cash & equivalents$31.8M-66.6%

Total debt$16.8M+40.9%

Total equity$327.6M-13.7%

Total assets$449.1M-6.9%

Cash flow

See full

Operating cash flow-$2.7M-2,089%

CapEx$2.2M+155%

Free cash flow-$4.9M-403%

Valuation

See full

Market cap$577.27M+54.5%

Enterprise value$562.23M+93.7%

P/S2.8×+0.9×

Profitability

See full

Gross margin51.7%-3.2pp

Operating margin-21.5%—

Net margin-36.2%—

FCF margin-6.2%-15.1pp

Returns & leverage

See full

Return on equity-20.9%—

Debt / equity0.1×0.0×

Current ratio4.7×-0.9×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NoncurrentAssets.

The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytek Biosciences, Inc.'s long-lived assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cytek Biosciences, Inc.'s long-lived assets?: Cytek Biosciences, Inc. (CTKB) reported long-lived assets of $20.47M in Q1 2026.